Cargando…

Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction

OBJECTIVE: Cartilage health is maintained in response to a range of mechanical stimuli including compressive, shear and tensile strains and associated alterations in osmolality. The osmotic-sensitive ion channel Transient Receptor Potential Vanilloid 4 (TRPV4) is required for mechanotransduction. Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, S., Meng, H., Inamdar, S., Das, B., Gupta, H., Wang, W., Thompson, C.L., Knight, M.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders For The Osteoarthritis Research Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799379/
https://www.ncbi.nlm.nih.gov/pubmed/33395574
http://dx.doi.org/10.1016/j.joca.2020.08.002
_version_ 1783635121570578432
author Fu, S.
Meng, H.
Inamdar, S.
Das, B.
Gupta, H.
Wang, W.
Thompson, C.L.
Knight, M.M.
author_facet Fu, S.
Meng, H.
Inamdar, S.
Das, B.
Gupta, H.
Wang, W.
Thompson, C.L.
Knight, M.M.
author_sort Fu, S.
collection PubMed
description OBJECTIVE: Cartilage health is maintained in response to a range of mechanical stimuli including compressive, shear and tensile strains and associated alterations in osmolality. The osmotic-sensitive ion channel Transient Receptor Potential Vanilloid 4 (TRPV4) is required for mechanotransduction. Mechanical stimuli inhibit interleukin-1β (IL-1β) mediated inflammatory signalling, however the mechanism is unclear. This study aims to clarify the role of TRPV4 in this response. DESIGN: TRPV4 activity was modulated glycogen synthase kinase (GSK205 antagonist or GSK1016790 A (GSK101) agonist) in articular chondrocytes and cartilage explants in the presence or absence of IL-1β, mechanical (10% cyclic tensile strain (CTS), 0.33 Hz, 24hrs) or osmotic loading (200mOsm, 24hrs). Nitric oxide (NO), prostaglandin E(2) (PGE(2)) and sulphated glycosaminoglycan (sGAG) release and cartilage biomechanics were analysed. Alterations in post-translational tubulin modifications and primary cilia length regulation were examined. RESULTS: In isolated chondrocytes, mechanical loading inhibited IL-1β mediated NO and PGE(2) release. This response was inhibited by GSK205. Similarly, osmotic loading was anti-inflammatory in cells and explants, this response was abrogated by TRPV4 inhibition. In explants, GSK101 inhibited IL-1β mediated NO release and prevented cartilage degradation and loss of mechanical properties. Upon activation, TRPV4 cilia localisation was increased resulting in histone deacetylase 6 (HDAC6)-dependent modulation of soluble tubulin and altered cilia length regulation. CONCLUSION: Mechanical, osmotic or pharmaceutical activation of TRPV4 regulates HDAC6-dependent modulation of ciliary tubulin and is anti-inflammatory. This study reveals for the first time, the potential of TRPV4 manipulation as a novel therapeutic mechanism to supress pro-inflammatory signalling and cartilage degradation.
format Online
Article
Text
id pubmed-7799379
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher W.B. Saunders For The Osteoarthritis Research Society
record_format MEDLINE/PubMed
spelling pubmed-77993792021-01-19 Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction Fu, S. Meng, H. Inamdar, S. Das, B. Gupta, H. Wang, W. Thompson, C.L. Knight, M.M. Osteoarthritis Cartilage Article OBJECTIVE: Cartilage health is maintained in response to a range of mechanical stimuli including compressive, shear and tensile strains and associated alterations in osmolality. The osmotic-sensitive ion channel Transient Receptor Potential Vanilloid 4 (TRPV4) is required for mechanotransduction. Mechanical stimuli inhibit interleukin-1β (IL-1β) mediated inflammatory signalling, however the mechanism is unclear. This study aims to clarify the role of TRPV4 in this response. DESIGN: TRPV4 activity was modulated glycogen synthase kinase (GSK205 antagonist or GSK1016790 A (GSK101) agonist) in articular chondrocytes and cartilage explants in the presence or absence of IL-1β, mechanical (10% cyclic tensile strain (CTS), 0.33 Hz, 24hrs) or osmotic loading (200mOsm, 24hrs). Nitric oxide (NO), prostaglandin E(2) (PGE(2)) and sulphated glycosaminoglycan (sGAG) release and cartilage biomechanics were analysed. Alterations in post-translational tubulin modifications and primary cilia length regulation were examined. RESULTS: In isolated chondrocytes, mechanical loading inhibited IL-1β mediated NO and PGE(2) release. This response was inhibited by GSK205. Similarly, osmotic loading was anti-inflammatory in cells and explants, this response was abrogated by TRPV4 inhibition. In explants, GSK101 inhibited IL-1β mediated NO release and prevented cartilage degradation and loss of mechanical properties. Upon activation, TRPV4 cilia localisation was increased resulting in histone deacetylase 6 (HDAC6)-dependent modulation of soluble tubulin and altered cilia length regulation. CONCLUSION: Mechanical, osmotic or pharmaceutical activation of TRPV4 regulates HDAC6-dependent modulation of ciliary tubulin and is anti-inflammatory. This study reveals for the first time, the potential of TRPV4 manipulation as a novel therapeutic mechanism to supress pro-inflammatory signalling and cartilage degradation. W.B. Saunders For The Osteoarthritis Research Society 2021-01 /pmc/articles/PMC7799379/ /pubmed/33395574 http://dx.doi.org/10.1016/j.joca.2020.08.002 Text en © 2020 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fu, S.
Meng, H.
Inamdar, S.
Das, B.
Gupta, H.
Wang, W.
Thompson, C.L.
Knight, M.M.
Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction
title Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction
title_full Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction
title_fullStr Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction
title_full_unstemmed Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction
title_short Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction
title_sort activation of trpv4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking il-1β mediated articular cartilage matrix destruction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799379/
https://www.ncbi.nlm.nih.gov/pubmed/33395574
http://dx.doi.org/10.1016/j.joca.2020.08.002
work_keys_str_mv AT fus activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction
AT mengh activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction
AT inamdars activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction
AT dasb activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction
AT guptah activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction
AT wangw activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction
AT thompsoncl activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction
AT knightmm activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction